FeesSafety
Pluang+

HCW Biologics reports Q3 2026 results, advances clinical trials for autoimmune and cancer therapies.

Company Fundamentals
16 Nov 2026, 15:15 WIB
GlobeNewsWire
View Source
Bullish
HCW Biologics reports Q3 2026 results, advances clinical trials for autoimmune and cancer therapies.

HCW Biologics announced its Q3 2026 financial results and clinical progress, including advancing its Phase 1 trial for HCW9302 in alopecia areata with good tolerance and no dose-limiting toxicities. The company highlighted promising preclinical data for its TRBC platform molecules, including HCW11-018b and HCW11-040, targeting solid tumors and immune checkpoint inhibition. It secured $8.6 million in equity and up to $10 million in debt financing to support ongoing trials and manufacturing. The Phase 1 readout and recommended Phase 2 dose for HCW9302 are expected in early 2027, with plans to file an IND for HCW11-018b in the first half of 2027. Despite progress, the company notes substantial doubt about its ability to continue without additional funding.

HCW Biologics' Q3 2026 update comes as 67 of 150 priced Health-sector US stocks on Pluang rose while 61 fell. For readers following health stocks, here is Pluang's market snapshot as of Nov 16, 2026 19:13 WIB: HIMS (Hims and Hers Health Inc) traded at USD 19.01 with a 1-day change of -3.65% and a typical hold time of 24 days; CNC (Centene Corp) was at USD 73.80, up 3.55%, with a typical hold time of 42 days; BKD (Brookdale Senior Living Inc.) stood at USD 8.85, down 3.49%, with a typical hold time of 9 days.

More News

Nike faces scrutiny over cost-cutting ahead of first investor day since 2017

Nike faces scrutiny over cost-cutting ahead of first investor day since 2017

Nike is under pressure to clarify its cost-cutting plans as it prepares for its first investor day since 2017, scheduled for November 16–17. Despite efforts led by CEO Elliott Hill to turn the company around, management expects revenue to decline by ...

Market News
Bearish
55 minutes ago
Jackery and Every Electric launch North America's first plug-in virtual power plant for renters in NYC.

Jackery and Every Electric launch North America's first plug-in virtual power plant for renters in NYC.

Jackery and Every Electric have partnered to create North America's first plug-and-play virtual power plant (VPP) for renters and apartment residents, starting in New York City. This innovative system uses portable power stations plugged into standar...

Market News
Bullish
1 hour ago
P-1 AI names retired Brig. Gen. Matt Isler GM for Aerospace and Defense to boost AI engineering efforts.

P-1 AI names retired Brig. Gen. Matt Isler GM for Aerospace and Defense to boost AI engineering efforts.

P-1 AI has appointed retired Brigadier General Matt Isler as General Manager for its Aerospace and Defense division. Isler brings nearly 30 years of military and industry experience, including leadership roles at Northrop Grumman and startup DEFCON A...

Market News
Bullish
1 hour ago
Saputo renews share buyback plan to repurchase up to 10% of public shares by Nov 2027

Saputo renews share buyback plan to repurchase up to 10% of public shares by Nov 2027

Saputo Inc. has renewed its Normal Course Issuer Bid (NCIB), allowing it to repurchase up to 22.5 million common shares, representing 10% of its public float, from November 19, 2026, to November 18, 2027. This move reflects Saputo's strategy to retur...

Company Fundamentals
Bullish
2 hours ago
GitGuardian expands program to alert companies of leaked credentials, boosting enterprise cybersecurity worldwide.

GitGuardian expands program to alert companies of leaked credentials, boosting enterprise cybersecurity worldwide.

GitGuardian has launched the Enterprise Good Samaritan Program to identify and notify companies about high-impact leaked credentials that could expose their systems to attackers. Using AI and expert analysis, the program traces leaks to affected orga...

Market News
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App